Table 3 Antimicrobial resistance among Escherichia coli isolates from chicken and human samples.

From: Public health threat of antimicrobial resistance and virulence genes in Escherichia coli from human-chicken transmission in Egypt

Antibiotic class

Antibiotic (concentration)

Resistant strains chickens (N = 18)

Total (N = 29) humans (N = 11)

Penicillins

AMP (10 µg)

18 (100%)

9(81.8%)

AMC (20/10 µg)

18(100%)

11(100%)

Cephalosporins

CTX (30 µg)

17(94.4%)

7(63.6%)

CAZ (30 µg)

18(100%)

8(72.7%)

CTR (30 µg)

15(83.3%)

0(0%)

Aminoglycosides

CN (10 µg)

6(33.3%)

1(9.1%)

Fluoroquinolones

CIP (5 µg)

13(72.2%)

2(%)

Quinolones

NA (30 µg)

16(88.8%)

0(%)

Tetracyclines

DO (30 µg)

16(88.8%)

1(9.1%)

TE (30 µg)

17(94.4%)

2(18.1%)

Sulfonamides

SXT (25 µg)

17(94.4%)

2(18.1%)

Phenicols

C (30 µg)

18(100%)

0(0%)

Polymyxins

COL (10 µg)

7(38.8%)

1(9.1%)

Nitrofuran

NIT (30 µg)

10(55.5%)

0(0%)